Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tecovirimat in Monkeypox Virus Disease
NCT05597735Phase 3Active, not recruiting
- Sponsor
- ANRS
- Start
- Mar 2023
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of tecovirimat in mpox, sponsored by ANRS. Started Mar 2023; status: active, not recruiting.
02
Drugs
tecovirimat
03
Conditions
mpox
Beyond the preview
Go deeper on NCT05597735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05597735.